NGS based diagnostics at its best
omics2view.consulting GbR and our partners have long-standing experience in NGS diagnostics. Due to the urgency of human genetic analyses in everyday clinical practice, we offer comparatively short turnaround times by competitive costs. Our diagnostic NGS applications:
- Diagnostic gene panels
- Whole-Exome Sequencing (WES)
- Whole-Genome Sequencing (WGS)
Elaborate reports
omics2view.consulting GbR are known for high-quality and elaborate reports. Following bioinformatic analysis of your sequencing data we compile reports that identify all relevant genetic changes and interpret them in relation to the initial clinical diagnosis. See our example report.
WES & WGS
We recommend WES/WGS to investigate a broad spectrum of genes for possible causes of diverse genetic diseases. Alternatively, gene panels are available for specific entities.
Our current diagnostic gene panels are
- Comprehensive Tumor Panel (636 genes)*
- Hereditary Cancer Panel (f 74 genes, m 79 genes)
- Hereditary Breast and Ovarian Cancer (26 genes)
- BRCA1 & BCRA2 (2 genes)
- Gastric Cancer (14 genes)
- Renal Carcinoma (11 genes)
- Prostate Cancer (13 genes)
- Melanoma (2 genes)
- Multiple Endocrine Neoplasia (3 genes)
- Thyroid Cancer (2 genes)
Material: Saliva, blood or DNA
*Material: Tissue, Liquid biopsy sample (whole blood)
- Parathyroid Carcinoma (2 genes)
- Familial Paraganglioma (5 genes)
- Retinoblastoma (1 gene)
- Chondrosarcoma (2 genes)
- Colorectal Cancer (23 genes)
- Pancreatic Cancer (12 genes)
- Endometrial Cancer (11 genes)
- Gastrointestinal Stromal Tumor (7 genes)
- Neurofibromatosis (2 genes)
- Pheochromocytoma (9 genes)
Your advantage
- Fully customized service
- Elaborate and detailed clinical report
- Short turnaround time
- Competitive prices
